Figure 7.
Schematic illustration of the prodrug vesicles for cancer immunotherapy by ICD induction and CD47 blockade. (A) Schematic design of the acidity and MMP-2 dual-responsive prodrug vesicles. (B) Simplified mechanism of prodrug vesicle -mediated chemo-immunotherapy and CD47 blockade to inhibit tumor growth, recurrence, and distant metastasis. Adapted with permission from . Copyright © 2019 John Wiley and Sons.93